Fee
| Component | Value |
|---|---|
| Provider fee | $125.00 |
Schedule and sources
- Fee edition
- October 1, 2026
- Record effective
- 2025-04-01
- Schedule edition
- July 22, 2026; effective July 1, 2026
- Official files
- Fee masterSchedule PDFOntario source page
Intravenous local anaesthetic infusion for central neuropathic pain..................................................................................... 125.00
Passages mentioning G387
INTRAVENOUS
+ G376 Newborn or infant ................................................................... 10.20
+ G379 Child, adolescent or adult ....................................................... 6.15
Note:
1.G376 or G379 apply to cryoprecipitate infusion.
2.G376 or G379 may not be claimed with x-rays as they are included in the service.
3.Except for G381, injections into established I.V. apparatus may not be claimed.
G389 Preparation and infusion of gamma globulin, per patient, per
day...................................................................................... 13.90
+ G380 Cutdown including cannulation as necessary......................... 27.05
G387 Intravenous local anaesthetic infusion for central neuropathic
pain..................................................................................... 125.00
Payment rules:
1. G387 is only insured for patients with central neuropathic pain who have first undertaken but
not responded to generally accepted medical therapy.
2. The physician submitting the claim for this service must remain in constant attendance
during the infusion and no part of the procedure may be delegated or G387 is not payable.
3. G387 is limited to a maximum of 6 per patient per 12 month period.
Medical record requirements:
The medical record for the service must document the prior medical therapy that the patient did
not respond to or G387 is not eligible for payment.[Commentary:
1.Central neuropathic pain is pain caused by a primary lesion or dysfunction that affects the
central nervous system.
2.At the time of this amendment to the Schedule of Benefits, generally accepted medical
therapy that would be required prior to G387 is treatment with both a tricyclic antidepressant
and at least one anticonvulsant. ]Fee master record
Master, record 2098. Record Layout PDF, page 1.
G38720250401999999990000125000000000000000000000000000000000000000000000000
Auxiliary master fields are preserved as raw scaled values. The linked layout calls them zero-filled, but this edition contains non-zero values. They are not presented as final dollar fees or PDF units.
| Field | Raw / scale 10,000 |
|---|---|
| provider | 00001250000 / 125 |
| assistant | 00000000000 / 0 |
| specialist | 00000000000 / 0 |
| anaesthetist | 00000000000 / 0 |
| non anaesthetist | 00000000000 / 0 |
Explanation
AI-generated. Unreviewed.
This is an intravenous local anaesthetic infusion for central neuropathic pain, listed under Intravenous in Injections or Infusions.
Watch out for
Insured only for patients with central neuropathic pain who first had generally accepted medical therapy without response. The physician must remain in constant attendance, no part may be delegated, and it is limited to 6 per patient per 12 month period.
Report an issue
Something off?
Report an issue with G387. Do not include patient names, health details or other personal information.